fashion -WSS

fashion

author：Wikipedia 2025-09-30 00:39:19 - browse：2464

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Wikipedia

WSS

Private equity could exacerbate cardiology's overuse problem, experts fear

Private equity could exacerbate cardiology's overuse problem, experts fear

PEPFAR is under serious threat — and so is global health

Pregnancy discrimination could be enabled by AI

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

How medical schools plan to diversify without affirmative action

leisure time

fashion

focus

Moonlake's readout produced a cash windfall. Risks remain

Diverse clinical trials: Why aren’t we there yet?

Supreme Court strikes down use of affirmative action

Regeneron agrees to White House price limits on anti

Trump demands the U.S. pay no more for drugs than other countries … again

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Pig kidney works a record two months in donated body

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Telehealth for opioid use disorder is lifesaving

knowledge

Congenital heart disease patients face new threat of heart failure

Popular nasal decongestant doesn't actually relieve congestion

Generate Biomedicines machine learning biotech raises $273M

FDA proposes changes to key medical devices approval pathway

Pfizer plans to depart BIO

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

Wikipedia

focus

focus